Human Immunology News Volume 10.03 | Jan 25 2022

    0
    55







    2022-01-25 | HIN 10.03


    Human Immunology News by STEMCELL Technologies
    Vol. 10.03 – 25 January, 2022
    TOP STORY

    Cathepsin S Contributes to Lung Inflammation in Acute Respiratory Distress Syndrome

    Human and mouse model bronchoalveolar lavage fluid samples were analyzed for the presence and activity of cathepsin S and its endogenous inhibitors.
    [American Journal of Respiratory and Critical Care Medicine]

    Abstract
    Free E-Book: Genome Editing Applications for Disease Modeling and Cell Therapy.
    PUBLICATIONSRanked by the impact factor of the journal

    Single‐Cell Immune Mapping of Melanoma Sentinel Lymph Nodes Reveals an Actionable Immunotolerant Microenvironment

    Researchers used mass cytometry by time-of-flight, flow cytometry, and T cell receptor immunosequencing to conduct simultaneous single-cell analyses of immune cells in the sentinel lymph nodes of melanoma patients.
    [Clinical Cancer Research]

    Abstract

    NLRP3 Inflammasome Activation in Human Peripheral Blood Mononuclear Cells Induced by Venoms Secreted PLAM2s

    Peripheral blood mononuclear cells were isolated by density gradient and incubated with RPMI, LPS, BthTX-I or BthTX-II isolated from Bothrops jararacussu venom, to evaluate viability, and the results showed that there was no cell death.
    [International Journal of Biological Macromolecules]

    Abstract

    Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity

    Scientists showed that polymorphonuclear-myeloid-derived suppressor cells were present in high numbers in the polymorphonuclear of patients with primary or metastatic lung tumor.
    [Frontiers in Immunology]

    Full Article

    Pan-Cancer Analysis of GALNTs Expression Identifies a Prognostic of GALNTs Feature in Low Grade Glioma

    Investigators used Oncomine and The Cancer Genome Atlas databases to analyze the transcription and survival effect of N-acetylgalactosaminyltransferase genes (GALNTs) in pan-cancer.
    [Journal of Leukocyte Biology]

    Abstract

    Tumor Microenvironment and Its Clinicopathological and Prognostic Associations in Surgically Resected Cutaneous Angiosarcoma

    Pretreated specimens were evaluated by immunohistochemistry for programmed cell death protein 1 and its ligand, densities of tumor infiltrative lymphocytes, as well as c-MYC and Ki-67 expressions.
    [Clinical and Translational Oncology]

    Abstract

    Physiological Levels of 25-Hydroxyvitamin D3 Induce a Suppressive CD4+ T Cell Phenotype Not Reflected in the Epigenetic Landscape

    The authors analyzed the influence of the precursor 25-hydroxyvitamin D3 on the differentiation of human CD4+ T cells applying physiological concentrations in vitro.
    [Scandinavian Journal of Immunology]

    Abstract

    Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients

    Researchers assessed the correlation between immune infiltration status, chemotherapeutics sensitivity, immune checkpoint proteins, and the signature.
    [Reproductive Sciences]

    Abstract
    Stop wasting time. Switch to a more efficient way to isolate cells. Learn more.
    REVIEWS

    Tissue-Resident Immune Cells in Humans

    Scientists propose a five-point checklist for defining resident immune cell types in humans and describe the currently known features of resident immune cells, their mechanisms of development, and their putative functional roles within various human organs.
    [Annual Reviews of Immunology]

    Abstract

    LRG1: An Emerging Player in Disease Pathogenesis

    Emphasis is given to the role that leucine-rich α-2 glycoprotein 1 (LRG1) plays as a vasculopathic factor where it disrupts the cellular interactions normally required for the formation and maintenance of mature vessels, thereby indirectly contributing to the establishment of a highly hypoxic and immunosuppressive microenvironment.
    [Journal of Biomedical Science]

    Full Article

    Biomarkers Related to Immune Checkpoint Inhibitors Therapy

    The development of biomarkers is important for monitoring the effect of treatment, assessing the patient’s response to immune checkpoint inhibitors, determining adverse reactions, and predicting the direction of disease development.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    First Patient Dosed in Phase I/IIa Trial of Lung Cancer Immunotherapy Vaccine

    Cancer Research UK, Vaccitech plc and the Ludwig Institute for Cancer Research, announced the first patient dosed in the MAGE trial, which is testing a novel immunotherapeutic, VTP-600, in patients with the most common type of lung cancer.
    [Ludwing Cancer Research]

    Press Release

    OSE Immunotherapeutics Receives First Notice of Allowance of a Patent for Use of Tedopi® after Failure with PD-1 or PD-L1 Immune Checkpoint Inhibitor Treatment in HLA-A2 Positive Cancer Patients

    OSE Immunotherapeutics SA announced that the Japanese Patent Office has issued the notice of allowance for a new patent covering Tedopi®, a combination of neoepitopes, for use after failure with PD-1 or PD-L1 immune checkpoint inhibitor treatment in HLA-A2 positive cancer patients.
    [OSE Immunotherapeutics SA]

    Press Release
    FEATURED EVENT

    Cell Therapy Analytics Symposium

    2 March, 2022
    Online

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Immunology, Immunotherapy, Brain Cancer

    National Cancer Institute – Bethesda, Maryland, United States

    Postdoctoral Position – NK Cell Therapy

    Oslo University Hospital – Oslo, Norway

    Postdoctoral Positions – Atherosclerosis

    Columbia University – New York, New York, United States

    Senior Researcher – Biology

    UK Research and Innovation – Oxfordshire, England, United Kingdom

    Scientist – CART T Cell Cancer Immunotherapies

    Children’s Hospital of Philadelphia – Philadelphia, Pennsylvania, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter